161 results on '"Tarnani, Michela"'
Search Results
2. Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience
3. Pulmonary infections in patients with acute myeloid leukemia receiving frontline treatment with hypomethylating agents
4. Treatment in patients with acute myeloid leukemia/high‐risk myelodysplastic syndrome with hypomethylating agents: Day‐hospital management compared to home care setting
5. Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience
6. Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022
7. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease
8. Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021
9. Azacytidine Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome: Day-Hospital Management Compared to Home Care Setting
10. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia
11. Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report
12. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome
13. Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration
14. A case of hemolytic anemia associated with interstitial lung disease, arthralgia and fever caused by Mycoplasma pneumoniae
15. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience
16. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients
17. Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients
18. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy
19. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia
20. Rituximab Therapy for Chronic Lymphocytic Leukemia-Associated Autoimmune Hemolytic Anemia
21. Acute Promyelocytic Leukemia in an HIV-Infected Patient: A Case Report
22. The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia
23. Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation
24. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia
25. New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia
26. Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience
27. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease
28. Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients
29. Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia.
30. Neurologic improvement after peripheral blood stem cell transplantation in poems
31. Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
32. Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome
33. Treatment of an HBs-Ag Positive Stem Cell Donor with Lamivudine to Prevent the Development of Hepatitis B in the Recipient
34. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
35. Reduced‐intensity conditioning allogeneic transplant in heavily pre‐treated chronic lymphocytic leukaemia patients: a single centre experience
36. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients
37. ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
38. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome
39. Circulating hematopoietic progenitor cells after autologous stem cell transplant for hematological malignancies
40. Overexpression of the Protein Tyrosine Phosphatase Lyp Reduces the Responsiveness of Chronic Lymphocytic Leukemia B-Cells to B-Cell Receptor Ligation.
41. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pre-treated patients with chronic lymphocytic leukemia
42. Multivariate Analysis of Prognostic Factors in CLL: A Study on 431 Patients Showing Usefulness of Novel Biological and Old Clinical Parameters in Predicting Shorter Survival: An Italian Multicentric Study
43. The Use of Low-Dose Alemtuzumab as Single Agent in the Treatment of Complication in Advanced Chronic Lymphocytic Leukaemia
44. Chronic Lymphocytic Leukemia With Eyelid Involvement Responding to Alemtuzumab
45. Simultaneous double mismatched cord blood transplantation in a young patient with secondary myelodysplastic syndrome: Feasibility and complications
46. Germline IgVH, del(17p13.1) and del(11q22.3) Predict Duration of Response in Patients Affected by Chronic Lymphocytic Leukaemia Treated with Oral Fludarabine and Cyclophosphamide as First-Line Therapy.
47. The Proliferative Response to CpG ODN Stimulation Predicts Disease Progression in B-Cell Chronic Lymphocytic Leukemia.
48. Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre‐transplant therapy
49. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia
50. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.